ATOSSA THERAPEUTICS INC (ATOS) Stock Cash Flow
NASDAQ:ATOS - Nasdaq - US04962H5063 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -26.91M | -30.09M | -26.96M | -20.61M | -17.83M | |||
| Depreciation Amortization | 26.00K | 23.00K | 10.00K | 20.00K | 50.00K | |||
| Change In Working Capital | 3.56M | 776.00K | -930.00K | -720.00K | -220.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.77M | 8.35M | 7.12M | 4.83M | 6.43M | |||
| OPERATING CASH FLOW | -19.55M | -20.94M | -20.76M | -16.47M | -11.57M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -23.00K | -14.00K | -30.00K | -10.00K | -10.00K | |||
| Other Investing Activity | N/A | 0.00 | -4.70M | N/A | N/A | |||
| INVESTING CASH FLOW | -23.00K | -14.00K | -4.73M | -10.00K | -10.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 309.00K | -1.48M | 0.00 | 113.30M | 38.55M | |||
| FINANCING CASH FLOW | 309.00K | -1.48M | 0.00 | 113.30M | 38.55M | |||
| CHANGE IN CASH | -19.26M | -22.43M | -25.49M | 96.82M | 26.97M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -19.55M | -20.94M | -20.76M | -16.47M | -11.57M | |||
| Capital Expenditure | -23.00K | -14.00K | -30.00K | -10.00K | -10.00K | |||
| FREE CASH FLOW | -19.57M | -20.95M | -20.79M | -16.48M | -11.58M | |||
All data in USD